Filed
ORBNOrion BioSystems, Inc.NASDAQ
Orion BioSystems Sets IPO Range Ahead of Nasdaq Listing
S-1/AIPO / ListingneutralImpact72
ORBN Price
Chart unavailableN/A$0.00 (+0.00%)
Chart unavailable
Why It Matters
IPO timing and float setup can drive first-day volatility before the company has trading history
Orion BioSystems filed IPO terms for 7.5M primary shares at $15.00 to $17.00, with expected first trading on Nasdaq after pricing
Bullish
- Proceeds fund lead program development
- Primary offering brings capital to issuer
- Nasdaq listing can expand investor access
Bearish
- No commercial revenue yet
- Clinical-stage losses remain material
- Limited float can amplify volatility
Key Evidence
- Price range set at $15.00 to $17.00
- 7.5M primary shares offered
- Expected first trade is Jun 5, 2026
What To Watch Next
- EFFECT notice and final pricing
- 424B4 final prospectus after pricing
- First-day trading volume and stabilization support
AdvertisementResponsive display
AdvertisementResponsive display
ORBN Market Context
SectorHealthcare
IndustryBiotechnology
Themeipo_listing
Sub-themetraditional_ipo